Psoriatic arthritis: Recognition and management

BioDrugs

Volumn 9, Issue 4, 1998, Pages 271-278

  Bruce, Ian N ^a   Gladman, Dafna D ^a,b  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AURANOFIN; CALCITRIOL; CHLOROQUINE; CORTICOSTEROID; CYCLOSPORIN; ETRETINATE; FISH OIL; GOLD; ICOSAPENTAENOIC ACID; INDOMETACIN; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PSORALEN; SALAZOSULFAPYRIDINE; TOLMETIN;

CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED STUDY; GASTROINTESTINAL TOXICITY; HUMAN; INTRAARTICULAR DRUG ADMINISTRATION; INTRAMUSCULAR DRUG ADMINISTRATION; LIVER TOXICITY; ORAL DRUG ADMINISTRATION; PNEUMONIA; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; PUVA; RANDOMIZED CONTROLLED TRIAL; RASH; REVIEW; SUNLIGHT; TERATOGENICITY;

EID: 0031979564     PISSN: 11738804     EISSN: None     Source Type: Journal    
DOI: 10.2165/00063030-199809040-00002     Document Type: Review

References (49)

1. Moll JMH, Wright V. Psoriatic arthritis. Semin Arthritis Rheum 1973; 3: 55-78
2. Alibert JL. Precise theorique et practique sur les maladies de la peau. Paris: Caille et Ravier, 1818
3. Wright V. Psoriasis and arthritis. Ann Rheum Dis 1956; 15: 348-56
4. O'Neill T, Silman A. Psoriatic arthritis: historical background and epidemiology. Baillieres Clin Rheumatol 1994; 8: 245-61
5. Gladman DD, Shuekett R, Russell ML, et al. Psoriatic arthritis: clinical and laboratory analysis of 220 patients. Q J Med 1987; 62: 127-41
6. Moll JMH. The place of psoriatic arthritis in the spondarthritides. Ballieres Clin Rheumatol 1994; 8: 395-417
7. Veale D, Rogers S, Fitzgerald O. Classification of clinical subsets in psoriatic arthritis. Br J Rheumatol 1994; 33: 133-8
8. Jones SM, Armas JB, Cohen MG, et al. Psoriatic arthritis: outcome of disease subsets and relationship of joint disease to nail and skin disease. Br J Rheumatol 1994; 33: 834-9
9. Buskila D, Langevitz P, Gladman DD, et al. Patients with rheumatoid arthritis are more tender than those with psoriatic arthritis. J Rheumatol 1992; 19: 1115-9
10. Helliwell P, Marchesoni A, Peters M, et al. A re-evaluation of the osteoarticular manifestations of psoriasis. Br J Rheumatol 1991; 30: 339-45
11. Gladman DD. Natural history of psoriatic arthritis. Baillieres Clin Rheumatol 1994; 8: 179-94
12. Coulton BL, Thomson K, Symmons DP, et al. Outcome in patients hospitalized for psoriatic arthritis. Clin Rheumatol 1989; 8: 261-5
13. Torre Alonso JC, Rodrigues Perez A, Arribas Castrillo JM, et al. Psoriatic arthritis (PA): a clinical, immunological and radiological study of 180 patients. Br J Rheumatol 1991; 30: 245-50
14. Gladman DD, Farewell VT, Nadeau C. Clinical indicators of progression in psoriatic arthritis (PSA): multivariate relative risk model. J Rheumatol 1995; 22: 675-9
15. Gladman DD, Farewell VT. The role of HLA antigens as indicators of disease progression in psoriatic arthritis. Arthritis Rheum 1995; 38: 845-50
16. Abu-Shakra M, Gladman DD. Aetiopathogenesis of psoriatic arthritis. Rheumatol Rev 1994; 3: 1-7
17. Scarpa R, Puccino A, Iocco M, et al. The management of 138 psoriatic arthritic patients. Acta Derma Venereol 1989; 146 Suppl: 199-200
18. Baker H, Ryan TJ. Generalized pustular psoriasis: a clinical and epidemiological study of 104 cases. Br J Dermatol 1968; 80: 771-793
19. Carette S, Calin A, McCafferty JP, et al. Auranofin Cooperating Group. A double-blind placebo-controlled study of auranofin in patients with psoriatic arthritis. Arthritis Rheum 1989; 32: 158-65
20. Kirwan JR. The effect of glucocorticoids on joint destruction in rheumatoid arthritis. N Engl J Med 1995; 333: 142-6
21. Gladman DD, Blake R, Brubacher B, et al. Chloroquine therapy in psoriatic arthritis. J Rheumatol 1992; 19: 1724-6
22. Sayers ME, Mazanec DJ. Use of antimalarial drugs for the treatment of psoriatic arthritis. Am J Med 1992; 93 (4): 474-5
23. Newman ED, Perruquet JL, Harrington TM. Sulphasalazine therapy in psoriatic arthritis: clinical and immunologic response. J Rheumatol 1991; 18: 1379-82
24. Fraser SM, Hopkins R, Hunter JA, et al. Sulphasalazine in the management of psoriatic arthritis. Br J Rheumatol 1993; 32: 923-5
25. Gupta AK, Grober JS, Hamilton TA, et al. Sulfasalazine therapy for psoriatic arthritis: a double blind, placebo-controlled trial. J Rheumatol 1995; 22: 894-8
26. Clegg DO, Reda DJ, Mejias E, et al. Comparison of sulfasalazine and placebo in the treatment of psoriatic arthritis. Arthritis Rheum 1996; 39: 2013-20
27. Dougados M, vam der Linden S, Leirisalo Repo M, et al. Sulfasalazine in the treatment of spondylarthropathy: a randomized, mullicenter, double-blind, placebo-controlled study. Arthritis Rheum 1995; 38: 618-27
28. Palit J, Hill J, Capell HA, et al. A multicentre double-blind comparison of auranofin, intramuscular gold thiomalate and placebo in patients with psoriatic arthritis. Br J Rheumatol 1990; 29: 280-3
29. Bruckle W, Dexel T, Grasedyck K, et al. Treatment of psoriatic arthritis with auranofin and gold sodium thiomalate. Clin Rheumatol 1994; 13: 209-16
30. Mader R, Gladman DD, Long J, et al. Injectable gold for the treatment of psoriatic arthritis (PsA): long-term follow-up. Clin Invest Med 1995; 18: 139-43
31. Black RL, O'Brien WM, Van Scott EJ, et al. Methotrexate therapy in psoriatic arthritis: double blind study on 21 patients. JAMA 1964; 189: 743-7
32. Willkens RF, Williams HJ, Ward JR, et al. Randomized, double-blind, placebo controlled trial of low-dose pulse methotrexate in psoriatic arthritis. Arthritis Rheum 1984; 27: 376-81
33. Espinoza LR, Zakraoni L, Espinoza CG, et al. Psoriatic arthritis: clinical response and side effects of methotrexate therapy. J Rheumatol 1992; 19: 872-7
34. Abu-Shakra M, Gladman DD, Thorne JC, et al. Longterm methotrexate therapy in psoriatic arthritis: clinical and radiologic outcome. J Rheumatol 1995; 22: 241-5
35. Al-Awadhi A, Dale P, McKendry RJ. Pancytopenia associated with low dose methotrexate therapy: a regional survey. J Rheumatol 1993; 20: 1121-5
36. Hassan W. Methotrexate and liver toxicity: role of surveillance liver biopsy. Conflict between guidelines for rheumatologists and dermatologists. Ann Rheum Dis 1996; 55: 273-5
37. Lanse SB, Arnold GL, Gowans JDC, et al. Low incidence of hepatotoxicity associated with long-term, low dose oral methotrexate in treatment of refractory psoriasis, psoriatic arthritis and rheumatoid arthritis. Dig Dis Sci 1985; 30: 104-9
38. Steinsson K, Jonsdottir I, Valdimarsson H. Cyclosporin A in psoriatic, arthritis: an open study. Ann Rheum Dis 1990; 49: 603-6
39. Spadaro A, Riccieri V, Sili-Scavalli A, et al. Comparison of cyclosporin A and methotrexate in the treatment of psoriatic arthritis: a one-year prospective study. Clin Exp Rheumatol 1995; 13: 589-93
40. Tugwell P, Pincus T, Yocum D, et al. Combination therapy with cyclosporine and methotrexate in severe rheumatoid arthritis. N Engl J Med 1995; 333: 137-41
41. Klinkhoff AV, Gertner E, Chalmers A, et al. Pilot study of etretinate in psoriatic arthritis. J Rheumatol 1989; 16: 789-91
42. Hopkins R, Bird HA, Jones H, et al. A double-blind controlled trial of etretinate and ibuprofen in psoriatic arthritis. Ann Rheum Dis 1985; 44: 189-93
43. Perlman SG, Gerber LH, Roberts M, et al. Photochemotherapy and psoriatic arthritis: a prospective study. Ann Intern Med 1979; 91: 717-22
44. Sukenik S, Giryes H, Halevy S, et al. Treatment of psoriatic arthritis at the Dead Sea. J Rheumatol 1994; 21: 1305-9
45. Snellman E, Lauharanta J, Reunanen A, et al. Effect of heliotherapy on skin and joint symptoms in psoriasis: a 6-month follow-up study. Br J Dermatol 1993; 128: 172-7
46. Huckins D, Felson DT, Holick M. Treatment of psoriatic arthritis with oral 1,25 dihydroxyvitamin D3: a pilot study. Arthritis Rheum 1990; 33: 1723-7
47. Bittener SB, Tucker WFG, Cartwright I, et al. A double-blind, randomized, placebo-controlled trial of fish oil in psoriasis. Lancet 1988; 1: 378-80
48. Veale D, Torley H, Richards I, et al. A double-blind, placebo-controlled trial of Efamol Marine on skin and joint symptoms of psoriatic arthritis. Br J Rheumatol 1994; 33: 954-8
49. Peloso P, Gladman DD. Fish oils in the treatment of psoriatic arthritis: an open study [abstract]. Arthritis Rheum 1992; 35 Suppl 9.: S225